Novo says Wegovy lowered BMI and obesity rates in children in a trial
Novo said a trial found that Wegovy injections lowered BMI and obesity rates in children; no obesity medications are currently approved for children under 12.Novo said a trial found that Wegovy injections lowered BMI and obesity rates in children. Wegovy is already approved to treat obesity in children aged 12 and older, but the supplied account says no medications are currently approved for children under 12.
cnbc.com (English) ↗+ Save